CClinicalTrials.gg
Status unknownNCT03813264Updated Jan 23, 2019

Optimizing Outcomes of Dynamic Psychotherapy by the MATRIX: A Preliminary Study

An interventional study of Routine outcome measures (ROM) in Psychotherapy, Mental Health and Monitoring, sponsored by Shalvata Mental Health Center. Status unknown at 1 site in Israel. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-01-23.

Sponsored by Shalvata Mental Health Center · Not applicable, Interventional, and Health services research

The sponsor has not verified this record recently (last verified Jan 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Mental disorders require therapeutic effort that contains drug components and psychotherapeutic intervention. The latter requires many resources in light of the skill required. Moreover, such intervention is long, and it takes a long time to assess its effectiveness. The proposed study seeks to implement a management system (ie, a system that monitors and intervenes in ineffective and even harmful treatments) for the purpose of optimizing psychotherapies. The system monitors the improvement in patients' condition in treatment using a mobile phone-based system, and when the treatment is ineffective, it recommends correction strategies. The study will help reduce the ineffective or harmful treatment in dynamic psychotherapy, increasing the quality of care the patient receives. And will lead to the optimal utilization of resources in the mental health system.

Read the detailed description

The purpose of the proposed study is to examine, on a preliminary basis, the feasibility of a monitoring and intervention system that will enable the identification and even improvement of ineffective (and even harmful) hours of therapy in dynamic psychotherapy.

The study will take place in the clinic complex located at the Shalvata Mental Health Center campus (Shalva clinic, departmental follow-up clinics, day department), and will include 10 therapists (psychiatrists, psychologists, social workers) and 10 patients.The duration of the study will be two months. Once the patient and the therapist have signed an informed consent form, they will be integrated into a cellular-based routine outcome monitoring (ROM) that is developed specifically for the present study. This system, which is completely separate from the clinical systems of the Center, is operated after each session by the therapist. Its activation sends an SMS to the patient and to the therapist, in which a referral to a designated and secure site in which questionnaires are administered in order to measure the patient's condition and the assessment of the therapist and the patient regarding the quality of the therapeutic session. In addition, during the entire study period, the hours of treatment will be recorded in a dedicated manual recording device. This is done routinely in many research institutes in Israel and around the world, with the aim of approving the analysis of inefficient or harmful treatment hours. Treatment hours based on ROM data that have a negative effect (ie, evaluated negatively by the patient) will be transcribed by the therapist, and will undergo full MATRIX analysis. In each treatment pair, an analysis of up to two hours will be possible throughout the four months of the study. This analysis includes the conversion of the text to MATRIX codes, 3-letter codes that mark the section speaker (patient or therapist), the subject of the section (patient, therapist, or both) and its character (whether it deals with the ability to experience [ , Or the relationship between experiences [interrelation]). The coding will be performed by the principal investigator or by the secondary investigator. After the encoding analysis, a MATRIX-based feedback will be given by the Principal Investigator to the therapist, in which the recommendations of the analysis will be submitted.

The proposed study combines routine conventional follow-up practices (ROM) in psychotherapy with innovative analysis tools (MATRIX), and seeks to be a first and significant step in addressing the urgent need to implement managed care in psychotherapy. This has far-reaching implications for the management of mental health care in community, clinic, day care and hospitalization units.

02

Conditions studied

  • Psychotherapy
  • Mental Health
  • Monitoring

Keywords

  • MATRIX
  • ROM (Routine Outcome Measures)
  • mobile-assisted PROMS
  • managed care
03

In context

Lead sponsor

Shalvata Mental Health Center is the lead sponsor of 73 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Subjects (patients / therapists) over the age of 18.
  • had agreed to participate in the study.
  • eligible for psychotherapeutic treatment.
  • treated with the attending clinician for at least two months.
  • treated/treating with dynamic psychotherapeutic treatment only.

Exclusion criteria

Exclusion Criteria:

  • Patients who (due to cognitive impairment, language gaps, etc.) are unable to complete a questionnaire with little help.
05

Study design

Phase
Not applicable
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    preliminary arm

    pairs of patients and their therapists

    Other: Routine outcome measures (ROM)

Interventions

  • OtherRoutine outcome measures (ROM)

    The proposed study consists of two complementary processes: the first is the routine collection of clinical data using ROM; The second process is MATRIX-based intervention that is expected to improve the course of treatment.

    Also known as: MATRIX (a tool for analysis of therapeutic hours)

06

What researchers measure

Primary outcomes

  1. implementation of patient/therapist mobile phone based routine monitoring tools in public psychiatric services.

    high adherence rate of routine mobile based measures

    Time frame: 12 months

  2. efficiency of a platform that combine monitor and intervene clinical practice

    outcome of psychotherapeutic treatments based on the collection of routine outcomes \[ROM\] and analysis of MATRIX as measured by the OQ-45 (the most common outcome questionnaire in psychotherapy).

    Time frame: 12 months

07

Study locations

1 site
  • Shalvata Mental Health center
    Hod Hasharon,, Israel
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 23, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03813264
Lead sponsor
Shalvata Mental Health Center
Responsible party
Shlomo Mendlovich (director of the Shalvata Mental Health Center, Shalvata Mental Health Center) — Principal investigator
First posted
Jan 23, 2019
Start date
Jan 2019 (estimated)
Primary completion
Dec 2019 (estimated)
Completion
Jun 2020 (estimated)
Last update
Jan 23, 2019

Study contacts

Shlomo Mendlovich, MD
Contact
mendlovich@clalit.org.il
+972506770178
Hanna Lanchinsky, Mrs
Contact
hanaln@clalit.org.il
+97297478644

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion